ImmunoNewco: The background story emerges
Just over six weeks ago, we broke the news that 5AM Ventures had plunked $3.3 million into a stealthy biotech it was calling ImmunoNewco, and a few weeks later speculated further that the startup might be engaged in a pharmacogenomic “rescue” of immune-modulating drugs acquired from the low-profile Danish biotech Borean Pharma.
Well, I was largely right — but still partly wrong — about the goings-on at ImmunoNewco. I recently spoke with the company’s new… Continue Reading
5AM Ventures’ stealthy $3.3M, immune-related startup
(UPDATED: See below.)
5AM Ventures has invested $3.3 million in an immunology startup so far known only as ImmunoNewco. Andy Schwab, a co-founder of 5AM, confirmed the investment but declined to provide further details, saying only that “we’re still putting ImmunoNewco together.”
ImmunoNewco — a name that will change once the startup takes shape — is currently based in Menlo Park, Calif., which also happens to be where 5AM is located. The company will focus on immunology and… Continue Reading